Innovative models to accelerate antibody drug discovery
Biocytogen is a preclinical contract research organization that provides integrated solutions for next-generation antibody drug discovery to the global biomedical communities. Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including humanized & custom animal model generation, therapeutic antibody discovery (via RenMab™ mice), and in vivo/in vitro preclinical validation studies. Together, we discover innovative medicines for a better, healthier world.